Abstract
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), and Bath Ankylosing Spondylitis Global Score (BAS-G) have been recommended for evaluating function and disability in patients with ankylosing spondylitis (AS). The aim of this study was to develop a Chinese version of the BASDAI, BASFI, and BAS-G and assess their reliability and validity. The Chinese version was obtained after a translation and back-translation process. A total of 447 patients with adult and juvenile AS were assessed using these three instruments. Reliability was tested by internal consistency and test–retest reliability. Internal consistency of the instrument was given as Cronbach’s alpha. Test–retest reliability was assessed by intraclass correlation coefficient. To assess the sensitivity to change, 153 patients were included in an 8-week follow-up study. In our analysis, the reliability of these three instruments—the BASDAI, BASFI, and BAS-G—for a 24-h test–retest showed acceptable intraclass correlation coefficients (0.92–0.94). Our Chinese versions of the BASDAI, BASFI, and BAS-G also showed 0.87, 0.94, and 0.90, respectively, with Cronbach’s alpha coefficient, indicating good reliability. For sensitivity to change in 8-week follow-up, all three instruments showed 5.0 to 5.4% changes. Our Chinese versions of the BASDAI, BASFI, and BAS-G showed adequate reliability, validity, and responsiveness to clinical change. Thus, disease activity and functional status in Chinese-speaking patients with AS may be adequately evaluated with these versions of the original instruments.
Similar content being viewed by others
Abbreviations
- AS:
-
ankylosing spondylitis
- JAS:
-
juvenile onset disease
- AAS:
-
adult onset disease
- BASDAI:
-
Bath Ankylosing Spondylitis Disease Activity Index
- BASFI:
-
Bath Ankylosing Spondylitis Functional Index
- BAS-G:
-
Bath Ankylosing Spondylitis Global Score
- VAS:
-
visual analogue scales
- ESR:
-
erythrocyte sedimentation rate
- CRP:
-
C-reactive protein
References
Cuellar ML, Espinoza LR (1996) Management of spondyloarthropathies. Curr Opin Rheumatol 8:288–295
Leirisalo-Repo M (1998) Therapeutic aspects of spondyloarthropathies—a review. Scand J Rheumatol 27:323–328
Khan MA, van der Linden SM (1990) Ankylosing spondylitis and other spondyloarthropathies. Rheum Dis Clin North Am 16:551–579
Brown MA, Jepson A, Young A, Whittle HC, Greenwood BM, Wordsworth BP (1997) Ankylosing spondylitis in West Africans—evidence for a non-HLA-B27 protective effect. Ann Rheum Dis 56:68–70
Khan MA, Braun WE, Kushner I, Grecek DE, Muir WA, Steinberg AG (1977) HLA B27 in ankylosing spondylitis: differences in frequency and relative risk in American Blacks and Caucasians. J Rheumatol Suppl 3:39–43
Gonzalez-Roces S, Alvarez MV, Gonzalez S, Dieye A, Makni H, Woodfield DG et al (1997) HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 49:116–123
Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH (1994) Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 21:302–306
Chou CT, Chen JM, Hsu CM, Chen SJ (2003) HLA-B27 and its subtypes in 4 Taiwanese aborigine tribes: a comparison to Han Chinese patients with ankylosing spondylitis. J Rheumatol 30:321–325
Riley MJ, Ansell BM, Bywaters EG (1971) Radiological manifestations of ankylosing spondylitis according to age at onset. Ann Rheum Dis 30:138–148
Marks SH, Barnett M, Calin A (1982) A case-control study of juvenile- and adult-onset ankylosing spondylitis. J Rheumatol 9:739–741
Garcia-Morteo O, Maldonado-Cocco JA, Suarez-Almazor ME, Garay E (1983) Ankylosing spondylitis of juvenile onset: comparison with adult onset disease. Scand J Rheumatol 12:246–248
Dawes PT (1999) Stoke ankylosing spondylitis spine score. J Rheumatol 26:993–996
van der Heijde D, Spoorenberg A (1999) Plain radiographs as an outcome measure in ankylosing spondylitis. J Rheumatol 26:985–987
van der Heijde D, Calin A, Dougados M, Khan MA, van der Linden S, Bellamy N (1999) Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. J Rheumatol 26:951–954
Bellamy N, Muirden KD, Brooks PM, Barraclough D, Tellus MM, Campbell J (1999) A survey of outcome measurement procedures in routine rheumatology outpatient practice in Australia. J Rheumatol 26:1593–1599
Calin A, Edmunds L, Kennedy LG (1993) Fatigue in ankylosing spondylitis—why is it ignored? J Rheumatol 20:991–995
Jones SD, Koh WH, Steiner A, Garrett SL, Calin A (1996) Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. J Rheumatol 23:487–490
Ward MM (1999) Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 12:247–255
van Tubergen A, Coenen J, Landewe R, Spoorenberg A, Chorus A, Boonen A et al (2002) Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis Rheum 47:8–16
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291
Jones SD, Steiner A, Garrett SL, Calin A (1996) The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 35:66–71
van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368
Khan MA (2002) Update on spondyloarthropathies. Ann Intern Med 136:896–907
Claudepierre P, Sibilia J, Goupille P, Flipo RM, Wendling D, Eulry F et al (1997) Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy. J Rheumatol 24:1954–1958
Waldner A, Cronstedt H, Stenstrom CH (1999) The Swedish version of the Bath Ankylosing Spondylitis Disease Activity Index. Reliability and validity. Scand J Rheumatol Suppl 111:10–16
Cardiel MH, Londono JD, Gutierrez E, Pacheco-Tena C, Vazquez-Mellado J, Burgos-Vargas R (2003) Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol 21:451–458
Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285
Cronstedt H, Waldner A, Stenstrom CH (1999) The Swedish version of the Bath Ankylosing Spondylitis Functional Index. Reliability and validity. Scand J Rheumatol Suppl 111:1–9
Heikkila S, Viitanen JV, Kautianen H, Kauppi M (2000) Evaluation of the Finnish versions of the functional indices BASFI and DFI in spondylarthropathy. Clin Rheumatol 19:464–469
Haywood KL, Garratt AM, Jordan K, Dziedzic K, Dawes PT (2002) Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatol 41:1295–1302
Ruof J, Stucki G (1999) Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26:966–970
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wei, J.CC., Wong, RH., Huang, JH. et al. Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan. Clin Rheumatol 26, 1685–1691 (2007). https://doi.org/10.1007/s10067-007-0573-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0573-6